Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2023

MissionIRNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute … Continue reading

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – Why McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Is ‘One to Watch’

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. In addition, the company has a large exposure to copper through its subsidiary McEwen Copper, owner of the Los Azules copper deposit … Continue reading

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported that 67 patients have enrolled in the potentially pivotal phase 2 globally cited clinical study comparing drug candidate Berubicin’s effectiveness to second-line standard-of-care chemotherapy drug Lomustine. “The  company plans to have more than 200 … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) – Los Azules Project Could Be World’s Next Copper Unicorn

Historically, gold has been a staple in investment portfolios due to benefits like diversification and a lack of correlation with investments, retaining value during volatile periods. Despite the volatility in the gold market early in 2022, by the end of … Continue reading

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) to Present at BIO CEO & Investor Conference

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced that its CEO Amir Reichman will present at the BIO CEO & Investor Conference. … Continue reading

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Loop Global, Menzies Aviation on LAX Pilot Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is collaborating with Menzies Aviation and Loop Global Inc. on a pilot program at the Los Angeles International Airport; the program involves Mullen’s Class 1 EV cargo vans. The world’s … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Elevate Drug Delivery Across Blood-Brain Barrier by ~1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed its patented DehydraTECH(TM) technology, which is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. “DehydraTECH increases effectiveness and improves how these ingredients enter … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Inks Five New Contracts for More than a Dozen Machines

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and emergency systems, announced that it has entered five new contracts outlining sales for 13 more machines. The momentum the company created last year is carrying into 2023. The new … Continue reading

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands IP Portfolio with New USPTO Patent

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent 11,491,120, titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders in … Continue reading

Posted in Silo Pharma Inc. SILO | Leave a comment

MissionIRNewsBreaks – Data443 Risk Mitigation Inc.’s (ATDS) Product Suite Supporting Impressive Slate of Clients

Data443 Risk Mitigation (OTC: ATDS) has emerged as a key player within the cyber security space, strategically positioned to benefit from increased demand for data protection with its portfolio of software solutions that allow for a unified approach to data … Continue reading

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment